Investment and Corporate Development Manager at Wellington Partners · Joined 2024
View Live Interactive Profile →Dr. Lisa Gartenmann is Investment and Corporate Development Manager at Wellington Partners; the firm's team page lists her simply as Manager. She holds a D.Phil. in molecular cell biology from the Sir William Dunn School of Pathology at the University of Oxford, where she researched centrosome and centriole assembly and published in Cell, Developmental Cell, the Journal of Cell Biology and the Journal of Cell Science, and where she received a Departmental Prize Studentship and a Departmental Post-Doctoral Extension Award. She spent five and a half years as a strategy consultant in L.E.K. Consulting's life science division, leading strategy and transaction projects for pharma, biotech and private equity clients, including a year on secondment at AstraZeneca supporting data analytics and US precision medicine. She began at Wellington on secondment in the second half of 2024 and joined formally in 2025. No board seats or named investments are published.